Showing results (121-130 of 273) with videos related to
Sort By:
Pageof 28
Current Topics in Medicinal Chemistry|June 25, 2005
Dual COX-inhibitors: the answer is NO?Stefano Fiorucci, Elisabetta AntonelliInflammation & Allergy Drug Targets|April 15, 2006
NO-NSAIDs: from inflammatory mediators to clinical readoutsStefano Fiorucci, Elisabetta AntonelliInflammation & Allergy Drug Targets|February 1, 2011
Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDsStefano Fiorucci, Luca SantucciCurrent Opinion in Gastroenterology|March 21, 2009
Farnesoid X receptor agonists in biliary tract diseaseStefano Fiorucci, Franco BaldelliRecent Advances in Inflammation & Allergy Drug Discovery|April 29, 2025
COVID-19: An Updated View as of 2025Stefano Fiorucci, Ginevra UrbaniBiochemical Pharmacology|April 25, 2020
Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1Michele Biagioli, Adriana Carino, Silvia Marchianò, et al.Current Topics in Medicinal Chemistry|January 17, 2012
Molecular determinants of gastrointestinal and liver cancers: role of bile acid activated nuclear receptorsBarbara Renga, Andrea Mencarelli, Sabrina Cipriani, et al.Hepatology (Baltimore, Md.)|September 15, 2022
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injuryMichele Biagioli, Silvia Marchianò, Cristina di Giorgio, et al.Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|May 7, 2020
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasisAdriana Carino, Michele Biagioli, Silvia Marchianò, et al.Frontiers in Pharmacology|April 21, 2017
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver DiseasesCarmen Festa, Simona De Marino, Adriana Carino, et al.Pageof 28